CA2270995A1 - Improvements in or relating to screening for papilloma viruses - Google Patents

Improvements in or relating to screening for papilloma viruses

Info

Publication number
CA2270995A1
CA2270995A1 CA002270995A CA2270995A CA2270995A1 CA 2270995 A1 CA2270995 A1 CA 2270995A1 CA 002270995 A CA002270995 A CA 002270995A CA 2270995 A CA2270995 A CA 2270995A CA 2270995 A1 CA2270995 A1 CA 2270995A1
Authority
CA
Canada
Prior art keywords
screening
relating
papilloma viruses
organism
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002270995A
Other languages
French (fr)
Other versions
CA2270995C (en
Inventor
John Doorbar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Medical Research Council
John Doorbar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9625142A external-priority patent/GB9625142D0/en
Application filed by Medical Research Council, John Doorbar filed Critical Medical Research Council
Publication of CA2270995A1 publication Critical patent/CA2270995A1/en
Application granted granted Critical
Publication of CA2270995C publication Critical patent/CA2270995C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/084—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'

Abstract

Disclosed is a method of detecting a papilloma virus infection in an organism, the method comprising the steps of: obtaining a sample of the organism's cells from the site of potential infection; contacting the cells with a molecule that binds specifically to papilloma virus E4 protein; and monitoring said binding, together with a method of determining the types) of HPV infecting a patient, a method of screening a patient for the presence of a precancerous cervical lesion, and an antibody molecule of use in one of the above methods.
CA002270995A 1996-12-03 1997-12-03 Improvements in or relating to screening for papilloma viruses Expired - Fee Related CA2270995C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9625142A GB9625142D0 (en) 1996-12-03 1996-12-03 Virus identification
GB9625142.6 1996-12-03
GB9718745.4 1997-09-05
GBGB9718745.4A GB9718745D0 (en) 1996-12-03 1997-09-05 Improvements in or relating to screening for carcinoma
PCT/GB1997/003321 WO1998025145A1 (en) 1996-12-03 1997-12-03 Improvements in or relating to screening for papilloma viruses

Publications (2)

Publication Number Publication Date
CA2270995A1 true CA2270995A1 (en) 1998-06-11
CA2270995C CA2270995C (en) 2006-10-10

Family

ID=26310537

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002270995A Expired - Fee Related CA2270995C (en) 1996-12-03 1997-12-03 Improvements in or relating to screening for papilloma viruses

Country Status (11)

Country Link
US (2) US6346377B1 (en)
EP (1) EP1021722B1 (en)
JP (1) JP4206133B2 (en)
AT (1) ATE299594T1 (en)
AU (1) AU744391B2 (en)
CA (1) CA2270995C (en)
DE (1) DE69733721T2 (en)
DK (1) DK1021722T3 (en)
ES (1) ES2242236T3 (en)
GB (1) GB9718745D0 (en)
WO (1) WO1998025145A1 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9718745D0 (en) * 1996-12-03 1997-11-12 Medical Res Council Improvements in or relating to screening for carcinoma
US6303323B1 (en) * 1997-10-21 2001-10-16 Cancer Research Campaign Technology Limited Detection of dysplastic or neoplastic cells using anti-MCM5 antibodies
PT1179176E (en) * 1999-04-16 2006-07-31 Ortho Mcneil Pharm Inc METHOD FOR DETECTING T-CELLS SPECIFIC TO ANTIGEN
GB0018140D0 (en) * 2000-07-24 2000-09-13 Medical Res Council Screening for abnormalities
US20070031826A1 (en) * 2005-08-05 2007-02-08 My Gene Diagnostic kit for determining the genotype of a human papilloma virus and method of using thereof
US20100279422A1 (en) * 2006-08-21 2010-11-04 Cmed Technologies Ltd. Method of surface plasmon resonance (spr) technology to detect genomic disorders for prenatal diagnosis
WO2008036465A2 (en) * 2006-09-18 2008-03-27 CMED Technologies Ltd. Office of Walkers Limited A method to assess cancer susceptibility and differential diagnosis of metastases of unknown primary tumors
WO2008036470A2 (en) * 2006-09-19 2008-03-27 Cmed Technologies Ltd. A method for screening of infectious agents in blood
US20100021971A1 (en) * 2006-09-21 2010-01-28 Cmed Technologies Ltd. Method to remove repetitive sequences from human dna
US20100047815A1 (en) * 2006-09-21 2010-02-25 Cmed Technologies Ltd. Method to detect tumor markers and diagnosis of undifferentiated tumors
WO2008085554A2 (en) * 2006-09-25 2008-07-17 Cmed Technologies Ltd. A method to detect virus related immunologigal markers for the diagnosis of hepatitis b virus infection
US8119350B2 (en) * 2006-09-25 2012-02-21 Cmed Technologies Ltd Method of surface plasmon resonance (SPR) to detect genomic aberrations in patients with multiple myeloma
US20090311699A1 (en) * 2006-09-25 2009-12-17 Cmed Technologies Ltd. Method of surface plasmon resonance (spr) to detect genomic aberrations in patients with chronic lymphocytic leukemia
WO2008070227A2 (en) * 2006-09-25 2008-06-12 Cmed Technologies Ltd. A method for the identification of human immunodeficiency virus related antibodies in blood
US20100041018A1 (en) * 2006-09-25 2010-02-18 Cmed Technologies Ltd. Method to detect virus related immunological markers for the diagnosis of hepatitis c virus infection
US20100047789A1 (en) * 2006-09-25 2010-02-25 Cmed Technologies Ltd. Method of surface plasmon resonance (spr) to detect genomic disorders for postnatal diagnosis
WO2008066994A2 (en) * 2006-09-27 2008-06-05 Cmed Technologies Ltd. Application of surface plasmon resonance technology to maternal serum screening for congenital birth defects
WO2008067003A2 (en) * 2006-09-27 2008-06-05 Cmed Technologies Ltd. A method to detect virus related immunological markers for the diagnosis of respiratory tract infections
WO2008066997A2 (en) * 2006-09-27 2008-06-05 Cmed Technologies Ltd. A method for quantitative measurement of cardiac biochemical markers
WO2008067008A2 (en) * 2006-09-27 2008-06-05 Cmed Technologies Ltd. A method for the quantitative evaluation of sex hormones in a serum sample
WO2008066996A2 (en) * 2006-09-27 2008-06-05 Cmed Technologies Ltd. A method to detect treponema pallidum immunological markers for the diagnosis of syphilis
WO2008070241A2 (en) * 2006-09-27 2008-06-12 Cmed Technologies Ltd. A method to measure serum biomarkers for the diagnosis of liver fibrosis
GB2456690B (en) * 2006-09-28 2012-01-25 Cytotrend Biotech Engineering Ltd Usa Inc A method for quantitative detection of diabetes related immunological markers
US8158440B2 (en) * 2006-09-28 2012-04-17 Cmed Technologies Ltd. Method for quantitative measurement of thyroid related antibodies or antigens in a serum sample
US7838215B2 (en) * 2007-09-25 2010-11-23 Canvir, Inc. Advanced cervical cell screening methods
US8168379B2 (en) 2007-10-04 2012-05-01 Cmed Technologies Ltd. Application of surface plasmon resonance technology for detecting and genotyping HPV
GB0820720D0 (en) * 2008-11-12 2008-12-17 Norchip As Method for worldwide screening of pre-cancer epithelial disease of the cervix

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4777239A (en) * 1986-07-10 1988-10-11 The Board Of Trustees Of The Leland Stanford Junior University Diagnostic peptides of human papilloma virus
CA2038581A1 (en) * 1990-03-20 1991-09-21 Martin Muller Seroreactive epitopes of human papillomavirus (hpv) 16 proteins
SE9001705D0 (en) * 1990-05-11 1990-05-11 Medscand Ab SET FOR DIAGNOSTICS OF VIRUS BREAKING TUMORS BY IMMUNOASSAY
GB9718745D0 (en) * 1996-12-03 1997-11-12 Medical Res Council Improvements in or relating to screening for carcinoma

Also Published As

Publication number Publication date
GB9718745D0 (en) 1997-11-12
DK1021722T3 (en) 2005-08-08
JP2001509886A (en) 2001-07-24
EP1021722B1 (en) 2005-07-13
EP1021722A1 (en) 2000-07-26
CA2270995C (en) 2006-10-10
AU744391B2 (en) 2002-02-21
AU5231198A (en) 1998-06-29
ATE299594T1 (en) 2005-07-15
WO1998025145A1 (en) 1998-06-11
JP4206133B2 (en) 2009-01-07
ES2242236T3 (en) 2005-11-01
US7135281B2 (en) 2006-11-14
DE69733721D1 (en) 2005-08-18
DE69733721T2 (en) 2006-05-18
US6346377B1 (en) 2002-02-12
US20030175682A1 (en) 2003-09-18

Similar Documents

Publication Publication Date Title
CA2270995A1 (en) Improvements in or relating to screening for papilloma viruses
AU4694499A (en) Trace level detection of analytes using artificial olfactometry
CA2185555A1 (en) Integrated system for biological fluid constituent analysis
CA2412121A1 (en) Method for the detection of influenza a/b viruses
CA2392935A1 (en) Method and apparatus for non-invasive analysis of blood glucose
WO2001042502A3 (en) Methods for disease detection
BR0210210A (en) Biological measurement system
WO1998016645A3 (en) Compounds and methods for diagnosis of tuberculosis
RU94046284A (en) Method for detecting antibodies, method for performing c-cracking of blood components and set for detecting hcv-antibodies
SE9500023L (en) Ways to detect cancer
ATE169202T1 (en) DISPOSABLE DEVICE FOR COLLECTING SAMPLES AND, IF APPROPRIATE, ANALYZING BODY FLUID
EP0248534A3 (en) Method of detecting aids virus infection
EP1297147B8 (en) Compositions for the diagnosis and treatment of herpes simplex virus infection
EP1598654A3 (en) Assay kit and method for sample collection
CY1106349T1 (en) HEPATITIS C VIRUS ANTIGEN DETECTION SYSTEMS
AU2283792A (en) Direct detection of hepatitis c virus rna
EP0704528A3 (en) Rabbit hemorrhagic disease virus (RHDV) recombinant capsids and proteins, diagnostic kits and vaccines containing them
FR2757864B1 (en) ANTIBODIES SPECIFICALLY RECOGNIZING A NITROSYLATED PROTEIN, THEIR PREPARATION METHOD, THEIR THERAPEUTIC AND DIAGNOSTIC USE
CA2271092A1 (en) Immunohistochemical detection assay for carcinoma proliferative status
CA2213083A1 (en) Detection of antibody production
ATE370251T1 (en) DETECTION OF THE HUMAN PAPILLOMA VIRUS USING THE PAPANICOLAU TEST
CA2236837A1 (en) Detection of mammary tumor virus-like sequences in human breast cancer
ES8707798A1 (en) Processes for the detection of non-A, non-B hepatitis and a kit for use in the same.
WO1999024466A3 (en) Multi-mer peptides derived from hepatitis c virus envelope proteins for diagnostic use and vaccination purposes
CA2301716A1 (en) Diagnosis kit for skin test and method for carrying out the same

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20141203